Mutations in tau protein promote aggregation by favoring extended conformations
FICHOU, Yann
Chimie et Biologie des Membranes et des Nanoobjets [CBMN]
Institut Européen de Chimie et Biologie [IECB]
< Réduire
Chimie et Biologie des Membranes et des Nanoobjets [CBMN]
Institut Européen de Chimie et Biologie [IECB]
Langue
EN
Document de travail - Pré-publication
Résumé en anglais
Amyloid aggregation of the intrinsically disordered protein (IDP) tau is involved in several diseases, called tauopathies. Some tauopathies can be inherited due to mutations in the gene encoding tau, which might favor the ...Lire la suite >
Amyloid aggregation of the intrinsically disordered protein (IDP) tau is involved in several diseases, called tauopathies. Some tauopathies can be inherited due to mutations in the gene encoding tau, which might favor the formation of tau amyloid fibrils. This work aims at deciphering the mechanisms through which the diseases-associated single point mutations promote amyloid formation. We combined biochemical and biophysical characterization, notably small angle X-ray scattering (SAXS), to study six different FTDP-17 derived mutations. We found that the mutations promote aggregation to different degrees and can modulate tau conformational ensembles, intermolecular interactions and liquid-liquid phase separation propensity. In particular, we found a good correlation between the aggregation lag time of the mutants and their radius of gyration. We show that mutations disfavor intramolecular protein interactions, which in turn favor extended conformations and promote amyloid aggregation. This work proposes a new connection between the structural features of tau monomers and their propensity to aggregate, providing a novel assay to evaluate aggregation propensity of IDPs.< Réduire
Mots clés en anglais
Intrinsically disordered protein
SAXS
tau protein
amyloid
IDP conformation
Projet Européen
Cofactors at the core of tau prion behavior
Unités de recherche